fda - Search News

News

FDA expands warning about rare heart risk

Associated Press News on MSN · 2d

FDA requires updated warning about rare heart risk with COVID shots

U.S. health officials have expanded warnings about a rare heart side effect associated with the two leading COVID-19 vaccines.

Newsweek on MSN · 2d

COVID vaccines heart risk warning update issued by FDA

"The committee has been plagued with persistent conflicts of interest and has become little more than a rubber stamp for any vaccine," he wrote in an op-ed for The Washington Post. "It has never recommended against a vaccine—even those later withdrawn for safety reasons."

FDA expanding COVID vaccine warnings over rare heart side effect

The U.S. Food and Drug Administration is now requiring two common COVID-19 vaccines to update their warning labels to include information on two rare heart side effects. Myocarditis, or

1don MSN

Bay Area family shares frustrations after FDA rejects drug for ultra-rare Barth Syndrome

With the FDA recently rejecting a drug application that aims to help those living with Barth Syndrome, one Bay Area family is ...

1d

US FDA Eliminates Risk Evaluation and Mitigation Strategies for CAR-T Cancer Therapies

(Reuters) -The U.S. Food and Drug Administration said on Friday that it had eliminated the risk evaluation and mitigation ...

3d

FDA probes deaths of boys taking Sarepta Duchenne drug

The FDA said yesterday that it is investigating the deaths from liver failure of two non-ambulatory boys with Duchenne ...

Fierce Pharma4d

FDA investigates patient deaths after treatment with Sarepta's Duchenne gene therapy Elevidys

In one of the first major tests of the new FDA leadership’s regulatory philosophy toward gene therapies for rare diseases, ...

2d

FDA-approved drug may also treat alcoholism and withdrawal pain

A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.

4d

iTolerance, Inc. Appoints Former FDA Senior Executive Wayne Pines to the Board of Directors

June 25, 2025 / iTolerance, Inc. (”iTolerance” or the “Company”), an early-stage privately-held biotechnology company focused ...

MedPage Today2d

Experts Have Questions About FDA's New Priority Review Program

While there's little disagreement that speeding drug approvals would be a good thing, there are more questions than answers ...

Soy Carmín on MSN6h

Burger Trouble: Beloved Chain Faces New FDA Ban on Multiple Menu Items

A popular burger chain, a long-standing favorite for many, is now confronting a significant challenge as the Food and Drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results